University of Washington Center for Novel Therapeutics in Addiction Psychiatry — Seattle, Washington

University of Washington Center for Novel Therapeutics in Addiction Psychiatry is a clinical research site located in Seattle, Washington, United States 98195.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

University of Washington Center for Novel Therapeutics in Addiction Psychiatry has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Alcohol Use Disorder (AUD), PTSD.

Sponsors: Nathan Brashares Sackett.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Washington Center for Novel Therapeutics in Addiction Psychiatry?

University of Washington Center for Novel Therapeutics in Addiction Psychiatry has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Washington Center for Novel Therapeutics in Addiction Psychiatry conducted?

University of Washington Center for Novel Therapeutics in Addiction Psychiatry has 1 clinical trials on record, with 1 currently active. Their work covers Alcohol Use Disorder (AUD), PTSD.

Is University of Washington Center for Novel Therapeutics in Addiction Psychiatry accredited by Crixeo Health?

University of Washington Center for Novel Therapeutics in Addiction Psychiatry has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Washington Center for Novel Therapeutics in Addiction Psychiatry?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.